Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Neoplasms »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neoplasm, Residual < Neoplasms < Neoplasms, Experimental  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]
Ident.Authors (with country if any)Title
000194 (2020) Melissa Bersanelli [Italie]Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.
000420 (2019) Brittney Baer [États-Unis] ; Channing Vail Dudley [États-Unis] ; Rhea Micci Simons [États-Unis]Management Principles Associated With Cytokine Release Syndrome.
000544 (2019) Priya Hays [États-Unis] ; Caitlin Costello [États-Unis] ; Deepak Asudani [États-Unis]Clinical care of chimeric antigen receptor T-cell patients and managing immune-related adverse effects in the ambulatory and hospitalized setting: a review.
000555 (2019) Joseph H. Oved [États-Unis] ; David M. Barrett [États-Unis] ; David T. Teachey [États-Unis]Cellular therapy: Immune-related complications.
000803 (2018) Anne HolbrookIn patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms.
000808 (2018) Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie]Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.
000810 (2018) Daniel J. Pallin [États-Unis] ; Christopher W. Baugh [États-Unis] ; Michael A. Postow [États-Unis] ; Jeffrey M. Caterino [États-Unis] ; Timothy B. Erickson [États-Unis] ; Gary H. Lyman [États-Unis]Immune-related Adverse Events in Cancer Patients.
000903 (2018) Rossella Talotta [Italie] ; Fabiola Atzeni [Italie] ; Alberto Batticciotto [Italie] ; Maurizio Benucci [Italie] ; Sara Bongiovanni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance.
000934 (2018) Fereshteh Nazari [États-Unis] ; Alexander T. Pearson [États-Unis] ; Jacques Eduardo Nör [États-Unis] ; Trachette L. Jackson [États-Unis]A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment.
000965 (2017) Mari Kihara [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath D. Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
000A21 (2017) Charles SchmidtThe struggle to do no harm in clinical trials.
000A49 (2017) Sang Taek Kim [États-Unis] ; Jean Tayar [États-Unis] ; Van Anh Trinh [États-Unis] ; Maria Suarez-Almazor [États-Unis] ; Salvador Garcia [États-Unis] ; Patrick Hwu [États-Unis] ; Daniel Hartman Johnson [États-Unis] ; Marc Uemura [États-Unis] ; Adi Diab [États-Unis]Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series.
000A71 (2017) José Ram N Maneiro [Espagne] ; Alejandro Souto [Espagne] ; Juan J. Gomez-Reino [Espagne]Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis.
000B13 (2017) Hjalmar Wadström [Suède] ; Thomas Frisell [Suède] ; Johan Askling [Suède]Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
000B14 (2017) Raphaèle Seror [France] ; Xavier Mariette [France]Malignancy and the Risks of Biologic Therapies: Current Status.
000C11 (2017) Jasvinder A. Singh ; Alomgir Hossain ; Elizabeth Tanjong Ghogomu ; Amy S. Mudano [États-Unis] ; Lara J. Maxwell ; Rachelle Buchbinder ; Maria Angeles Lopez-Olivo ; Maria E. Suarez-Almazor ; Peter Tugwell ; George A. WellsBiologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
000D57 (2016) Masayoshi Harigai ; Toshihiro Nanki ; Ryuji Koike ; Michi Tanaka ; Kaori Watanabe-Imai ; Yukiko Komano ; Ryoko Sakai ; Hayato Yamazaki ; Takao Koike [Japon] ; Nobuyuki Miyasaka [Japon]Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
001088 (2015) Jean-François Rossi [France] ; Zhao-Yang Lu [France] ; Michel Jourdan [France] ; Bernard Klein [France]Interleukin-6 as a therapeutic target.
001183 (2015) Ling-Jun Ho [République populaire de Chine] ; Shue-Fen Luo [République populaire de Chine] ; Jenn-Haung Lai [République populaire de Chine]Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers.
001228 (2014) F. Pasquet [France] ; M. Pavic [France] ; J. Ninet [France] ; A. Hot [France][Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment].
001268 (2014) Xin Yao [États-Unis] ; Jiaqi Huang [États-Unis] ; Haihong Zhong [États-Unis] ; Nan Shen [République populaire de Chine] ; Raffaella Faggioni [États-Unis] ; Michael Fung [États-Unis] ; Yihong Yao [États-Unis]Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Neoplasms" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Neoplasms" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neoplasms
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021